No Picture
News

AXIM? Biotechnologies Completes Pre-Clinical Drug Studies on New Compound Proving Tenfold Greater Inhibition of Tumor Metastasis Than Parent Compound

SAN DIEGO, March 24, 2020 (GLOBE NEWSWIRE) — AXIM??Biotechnologies, Inc. (OTCQB: AXIM) (?AXIM? Biotech,? ?AXIM? or ?the Company?), an international healthcare solutions com […]

No Picture
News

SORRENTO COLLABORATES WITH MABPHARM ON DEVELOPMENT AND COMMERCIALIZATION OF ACE-MAB? TO POTENTIALLY TREAT COVID-19

SAN DIEGO, March 24, 2020 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced it has entered into an exclusive license agreement with China-based antibody biopharmaceutical company, Mabpharm Limited (Hong Kong S… […]

No Picture
News

Medical Marijuana, Inc. Investment Company AXIM? Biotechnologies Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc.

SAN DIEGO, March 24, 2020 /PRNewswire/ –?Medical Marijuana, Inc.?(OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands … […]

No Picture
News

NCCN Guidelines Designate Decipher Prostate as “Recommended” for Men with Adverse Pathology after Radical Prostatectomy

The first and only genomic test to achieve “Recommended” status for the management of prostate cancer patients

SAN DIEGO, March 24, 2020 /PRNewswire/ –?Decipher Biosciences, a commercial-stage precision oncology company committed to improving patien… […]

No Picture
News

A key player behind 2 multibillion-dollar biotech M&A deals is back in the startup business

Pratik Shah Pratik Shah and Aseem Ansari have snared a $45 million launch round for Design Therapeutics, a San Diego-based outfit that is focused on degenerative diseases linked to nucleotide repeat expansions. The biotech has identified a lead progra… […]